Children with juvenile rheumatoid arthritis (JRA) have been reported to require higher doses (per kg body weight) of methotrexate (MTX) than adults with rheumatoid arthritis to control their disease. The purpose of the present study was to characterise the plasma pharmacokinetics of MTX and its majo
Methotrexate hepatotoxic effects in children with juvenile rheumatoid arthritis
β Scribed by Alberto Martini; Angelo Ravelli; Stefania Viola; Roberto G. Burgio
- Book ID
- 117162501
- Publisher
- Elsevier Science
- Year
- 1991
- Tongue
- English
- Weight
- 210 KB
- Volume
- 119
- Category
- Article
- ISSN
- 1097-6833
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Twenty-three children with destructive polyarticular juvenile rheumatoid arthritis (JRA) were treated for 0 . 5 4 3 years (median 1.6 years) with weekly doses of methotrexate (MTX) (0.11-0.6 mg/kg/week). Serum levels of MTX at 1 hour and at 24 hours after drug administration were obtained at each do
## To assess the effects of methotrexate (MTX) therapy on radiologic progression in juvenile rheumatoid arthritis (JRA). Methods. We evaluated serial wrist radiographs for carpal length in 23 JRA patients with bilateral wrist involvement, before and during MTX treatment. These carpal length measur